A new project to accelerate research development in China led by the Centre for Eye Research Australia (CERA) kicked off last month in Guangzhou, China.

Known as the Australia-China Research Accelerator (ACRA), the program aims to standardise a data collection system and train Chinese hospital staff to conduct clinical research and collect data. This will allow hospitals to run multi-centred trials and encourage more investigator-initiated trials, and enable researchers to study rare eye diseases.

10 Chinese hospitals are now signed up for the program with hopes that number will increase to 50 next year. Since its commencement in 2015, the program has layed the basic groundwork, including an electronic data management system, a standardised training course and a hospital research capacity-development curriculum.

“China, as the world’s second largest economy and most populated nation, has an increasing demand for quality health services and medical research,” said Prof Mingguang He, who is leading the project. “ACRA facilitates a bridge between China and Australia and makes use of the advantages from both sides, to promote and accelerate the research development of this region.”

Prof He says ACRA is a long-term investment to build research infrastructure, quality and volume.

“This will provide us with greater evidence and data to answer the key questions affecting human health and medical services globally,” said Prof He.

CERA is a member of IAPB based in Melbourne, and this content is drawn from the CERA website.